Ramos Gustavo C, Rodrigues Claudiney M, Azevedo Geraldo M, Pinho Vanessa, Carvalho Cláudia R, Vaz Nelson M
Department of Pharmacology, CCB, Federal University of Santa Catarina, Florianópolis, SC, Brazil.
Immunology. 2009 Mar;126(3):354-62. doi: 10.1111/j.1365-2567.2008.02901.x. Epub 2008 Aug 28.
Oral tolerance promotes a generalized decrease in specific immune responsiveness to proteins previously encountered via the oral route. In addition, parenteral immunization with a tolerated protein also triggers a significant reduction in the primary responsiveness to a second unrelated antigen. This is generally explained by 'innocent bystander suppression', suggesting that the transient and episodic effects of inhibitory cytokines released by contact with the tolerated antigen would block responses to the second antigen. In disagreement with this view, we have previously shown that: (i) these inhibitory effects do not require concomitance or contiguity of the injections of the two proteins; (ii) that intravenous or intragastric exposures to the tolerated antigen are not inhibitory; and (iii) that the inhibitory effect, once triggered, persists in the absence of further contact with the tolerated protein, possibly by inhibition of secondary responsiveness (immunological memory). The present work confirms that immunological memory of the second unrelated antigen is hindered by exposure to the tolerated antigen and, in addition, shows that this exposure: (i) inhibits the inflammation triggered by an unrelated antigen through the double effect of inhibiting production of leucocytes in the bone marrow and blocking their migration to inflammed sites; and (ii) significantly blocks footpaw swelling triggered by carrageenan. Taken together, these results conclusively demonstrate that inhibitory effects of parenteral injection of tolerated antigens are much more general than suggested by the 'innocent bystander suppression' hypothesis.
口服耐受会促使机体对先前经口服途径接触过的蛋白质的特异性免疫反应性普遍降低。此外,用已产生耐受的蛋白质进行非口服途径免疫,也会引发对第二种无关抗原的初次反应性显著降低。这通常用“无辜旁观者抑制”来解释,即认为与耐受抗原接触后释放的抑制性细胞因子的短暂和间歇性作用会阻断对第二种抗原的反应。与这一观点不同的是,我们先前已经表明:(i)这些抑制作用并不要求两种蛋白质注射同时进行或相邻进行;(ii)静脉内或胃内接触耐受抗原并无抑制作用;(iii)抑制作用一旦触发,在不再接触耐受蛋白质的情况下仍会持续存在,可能是通过抑制二次反应性(免疫记忆)。目前的研究证实,接触耐受抗原会阻碍对第二种无关抗原的免疫记忆,此外,还表明这种接触:(i)通过抑制骨髓中白细胞的产生以及阻止其迁移至炎症部位的双重作用,抑制由无关抗原引发的炎症;(ii)显著阻断角叉菜胶引发的足爪肿胀。综上所述,这些结果确凿地证明,非口服途径注射耐受抗原的抑制作用比“无辜旁观者抑制”假说所表明的更为普遍。